Paper4139526
Live vaccine used to prevent the spread of varicella in children in hospital.
Takahashi M and 4 others. Lancet, 1974. Cited by 647 papers, by iCite.
Cite this record
ConductScience Library. Live vaccine used to prevent the spread of varicella in children in hospital. Papers, record 4139526. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4139526
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chickenpox | Major topic |
| Cross Infection | Major topic |
| Viral Vaccines | Major topic |
| Antibodies, Viral | |
| Child | |
| Child, Preschool | |
| Complement Fixation Tests | |
| Culture Techniques | |
| Female | |
| Herpesvirus 3, Human | |
| Humans | |
| Infant | |
| Injections, Subcutaneous | |
| Male | |
| Vaccines, Attenuated | |
| Virus Cultivation |
Source PubMed
Cited by219
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 647 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856419 | Fixed Nonsynonymous vOka Vaccine Mutations in IE62 drive Varicella-Zoster Virus Attenuation in Human Skin. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856419 | PubMed |
| 42781939 | Exploring the Development of Vaccine Platforms, With a Particular Focus on the COVID-19 Pandemic. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/42781939 | PubMed |
| 42775897 | Development and validation of a higher-throughput, automated FAMA assay for varicella-zoster virus antibody detection, offering a scalable alternative to the classic 12-well slide method. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42775897 | PubMed |
| 42693145 | Varicella zoster virus infection. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42693145 | PubMed |
| 42148760 | Whole-genome sequence of a varicella-zoster strain from an immunocompetent pediatric patient with severe herpes zoster. | Microbiol Resour Announc | 2026 | https://conductscience.org/library/papers/42148760 | PubMed |
| 41882884 | Modelling Impact of Different Varicella Immunisation Strategies Upon Introduction in the Swedish National Programme. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/41882884 | PubMed |
| 41846310 | Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review. | J Yeungnam Med Sci | 2026 | https://conductscience.org/library/papers/41846310 | PubMed |
| 41797638 | Genomic comparison reveals single-nucleotide polymorphic sites and attenuation-associated site combinations specific to Chinese live attenuated varicella-zoster virus vaccines. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41797638 | PubMed |
| 41600813 | Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral Vaccines. | Viruses | 2025 | https://conductscience.org/library/papers/41600813 | PubMed |
| 41379123 | Varicella vaccination in children with nephrotic syndrome. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/41379123 | PubMed |
| 41368914 | Effectiveness of Universal Varicella Vaccination after ten years of implementation in Tuscany (Central Italy). | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/41368914 | PubMed |
| 41341716 | Recurrent vaccine-strain varicella zoster virus reactivation in a child with acute lymphatic leukemia. | IDCases | 2025 | https://conductscience.org/library/papers/41341716 | PubMed |
| 41250651 | Varicella Vaccine Effectiveness and Duration of Protection: A Systematic Review and Meta-Analysis. | J Korean Med Sci | 2025 | https://conductscience.org/library/papers/41250651 | PubMed |
| 41150411 | Immune Persistence Following a Single Dose of Varicella Vaccine: 5-Year and 8-Year Follow-Up of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41150411 | PubMed |
| 40872323 | Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges. | Pathogens | 2025 | https://conductscience.org/library/papers/40872323 | PubMed |
| 40590155 | Investigation and analysis of influencing factors on the economic burden of varicella disease in Qingyang, China, 2024. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40590155 | PubMed |
| 40448056 | Immunogenicity and cellular response of a herpes zoster virus gEgI fusion protein adjuvanted with CpG-emulsion in mice. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40448056 | PubMed |
| 40389452 | A Spatial analysis of chickenpox in Chongqing, China, during 2015-2023. | Sci Rep | 2025 | https://conductscience.org/library/papers/40389452 | PubMed |
| 40295404 | Development of viral infectious clones and their applications based on yeast and bacterial artificial chromosome platforms. | Mol Biomed | 2025 | https://conductscience.org/library/papers/40295404 | PubMed |
| 40153527 | The live attenuated varicella-zoster virus vaccine vOka: Molecular and cellular biology of its skin attenuation. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40153527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4139526
GET https://conductscience.org/api/papers/v1/4139526/cited_by?page=2